CROSSLINKED CARBOXYMETHYL CELLULOSE

Platform

Bioitech has developed a standardized procedure (patent registered) for the synthesis and use of Crosslinked Carboxymethyl Cellulose injectable. This means owning the "platform", to potentially very large applications, going to develop specific and competitive devices, in all areas where the injectables are effectively used today.
Applications on which researchers of Bioitech are focusing for the foreseeable future, provide for the following uses:
-Dermal Filling: products that function as extracellular matrices used in dermatology, plastic surgery and aesthetic medicine, with filling function of tissue for correction of scars, depressions, sequelae of acne and wrinkle filling, shaping the face and volume of the lips.
-Ophthalmic Surgery: are used in corneal transplants, glaucoma, cataracts and retinal detachments as reconstruction of tissue and stimulators of tissue after surgery.
-Incontinenze: for urinary sphincter incontinenze and deficiencies in General.
-vocal cord atrophy: after neurological disorders or stroke, with hypertrophic function
-Orthopedic Applications: in vertebral break with helper function, in diseases and articular traumas.
-Anti-adhesive after surgery to prevent adhesions in Cavitary surgeries.
-External Dressings for wounds and burns, with Pach.
-Tissue engineering biomaterial research: drug delivery.

Dermal Filling

The development of Dermal fillers dates back to about 15-20 years ago, first with the collagens and later with Ialuronici acids, which thanks to the characteristics of total riassorbibilità have led to an improvement in the patient safety, avoiding the typical problems of permanent fillers as fluid silicone, which consisted of adverse reactions, sometimes severe.
The exponential growth of dermal filler market in recent years has also brought some large pharmaceutical companies to take an interest in this area.
Still today the know-how is the prerogative of a few small companies scattered throughout the world, mainly in France, Switzerland, Israel and United States, based mostly on isolated research and neglected for many years by large pharmaceutical companies. Currently in Italy Bioitech is one of the very few manufacturers of dermal fillers.
The device developed by Bioitech is part of a family of Dermal Fillers (regulated in Europe from MDD 93/42 EEC) used in dermatology, plastic surgery and aesthetic medicine, with filling function for correction of scars, depressions, sequelae of acne and wrinkle filling, shaping the face and volume of the lips. The Dermal Fillers are sold on the national territory and abroad, exclusively to medical specialists who use them on patients with intradermal injection and subcutaneous.